Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed InfluenzaJesús Castilla, Ferrán Barbé, Pere Godoy et al.|Clinical Infectious Diseases|2013Cited by 125
Delay in the Initiation of HAART, Poorer Virological Response, and Higher Mortality among HIV-Infected Injecting Drug Users in SpainM. Ángeles Rodríguez-Arenas, Inmaculada Jarrín, José Antonio Iribarren et al.|AIDS Research and Human Retroviruses|2006Cited by 69
Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in ChildrenJesús Castilla, Aurelio Barricarte, Manuel Garcìa Cenoz et al.|New England Journal of Medicine|2023Cited by 65
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Mariëtte Hooiveld, Virginia Martin et al.|Eurosurveillance|2021Cited by 55
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccinationSilvia Jiménez‐Jorge, Amparo Larrauri, Salvador de Mateo et al.|BMC Infectious Diseases|2013Cited by 55